FibriCheck’s pulse beating stronger than ever in 2021

We started 2021 off strong with a new investment round. The newly invested 9 million euros allowed us to further accelerate the growth of both our business units. While keeping one eye on international growth, the FibriCheck app is also rapidly evolving into a true integrated solution, making remote monitoring a reality via a full range of consumer devices including wearables and hearables.

Sister company Extra Horizon, in turn, is also seeing an increase in demand for technological support from companies looking to build secure, compliant and scalable medical applications.

FibriCheck goes down under with TGA certified app

Another big milestone was the launch of FibriCheck in Australia back in April, after previously being granted an Australian Register of Therapeutic Goods Certificate by the Australian Government Department of Health for our doctor-to-patient (D2P) model.

As the first stand-alone application of its kind to receive TGA clearance , this not only opened the Australian market, but also the wider Asia-Pacific region.

More clinical recognition

2021 also saw a significant increase in clinical evidence generation with no less than 20 studies being published across a wide range of authoritative publications, with even more in the pipeline.

Also of note: during the award session of the European Heart Rhythm Association’s annual congress, FibriCheck was featured in a head-to-head comparison with single-lead ECG algorithms, showing substantial equivalence between both technologies.

Specifically for Belgium, we joined forces with BeHRA, the Belgian Heart Rhythm Association as well as national newspaper Het Belang van Limburg for a nationwide campaign that allowed 10,000 people with a heightened CHA2DS2-VASc score to remotely monitor their heart rhythm.

“Thanks to BeHRA’s leadership position, we were able to field our solution on a large scale to identify the undetected health hazards of heart rhythm disorders as a result of the care postponed during the COVID crisis,” states FibriCheck CEO Lars Grieten.

Accelerating access across the pond

Notable strides are being made in the UK, where the new hypertension pathway framework guidance and AF pathway framework guidance cite FibriCheck’s remote heart rhythm monitoring as an example of clinical best practice in Primary Care for the restoration and improvement of proactive care.

Co-founder and 2020 NIA fellow Bieke Van Gorp: “We’re thrilled to see UK policymakers embrace digital solutions, not only as a way of shepherding us through these challenging times, but also as a way of making healthcare more efficient, less costly, and more effective at empowering patients to play a central role in managing their condition.”

We were also privileged to be recognised in the Primary Care Cardiovascular Society guidance for long-term CVD (cardiovascular disease) management during COVID.
The results of one such implementation, was published as a real world evidence case study for spread, illustrating the value of FibriCheck for frontline providers in delivering life-saving stroke prevention, despite pandemic pressures and restrictions.

Increase in strategic partnerships

2021 also marked the start of our collaboration with Digital Health London, after being accepted into their accelerator programme late last year. The programme offered us the opportunity to participate in various CVD network meetings, notably October’s innovation showcase, where decision makers from NHSE/I, NHSX and cardiology stakeholders attended our featured session on digital pathway transformation in the NHS. One case video that was presented highlights pathway redesign of post-stroke discharge in secondary care.

Want to know more about our other exciting partner projects? Have a look at the collaborations page on our website.

On the occasion of Heart Rhythm Week, FibriCheck partnered with global atrial fibrillation advocate, Arrhythmia Alliance, to help raise awareness around the most common heart rhythm disorder.

Looking forward to 2022

With a lot of exciting projects already in the pipeline, we are very much looking forward to 2022. But for now the entire FibriCheck team would like to wish you happy holidays and we hope to see you again next year!